Back
ESC Premium Access

Single antiplatelet therapy versus dual antiplatelet therapy after transcatheter aortic valve replacement: a meta-analysis of randomized controlled trials

Session: Interventional Cardiology ePosters
Topic: Aortic Valve Intervention
Speaker: Doctor G. Sayat (Quezon City, PH)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Glein Sayat

St Lukes Medical Center - Quezon City, Quezon City (Philippines)
0 follower

133 more presentations in this session

Vitamin D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention.

Speaker: Doctor M. Verdoia (Biella, IT)

Access
Abstract
Slides
Thumbnail

Effectiveness and prognostic value of intravscular imaging in patients with left main coronary artery stenosis and heart failure

Speaker: Associate Professor D. Maximkin (Moscow, RU)

Access
Abstract
Slides
Thumbnail

Late outcomes of percutaneous coronary interventions (PCI) and subsequent life-quality in patients younger 40 years of age

Speaker: Professor F. Abdullayev (Baku, AZ)

Access
Abstract
Slides
Thumbnail

Rapid pacing is an independent predictor for high implantation depth using self-expandable devices in TAVR

Speaker: Assistant Professor V. Veulemans (Duesseldorf, DE)

Access
Abstract
Slides
Thumbnail

Influence of the speed of deflation of the stent delivery system in the myocardial blush and st-segment resolution in primary angioplasty: a randomized study

Speaker: Doctor I. Lozano Martinez-Luengas (Gijon, ES)

Access
Abstract
Slides
Thumbnail

Access the full session

Interventional Cardiology ePosters

Speakers: Doctor G. Sayat, Doctor M. Verdoia, Associate Professor D. Maximkin, Professor F. Abdullayev, Assistant Professor V. Veulemans...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Cost-effective analysis of HOST-EXAM

27 August 2021

ESC Premium Access

Ticagrelor implementation in PCI-treated ACS patients

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

ESC 365 is supported by

logo Novo Nordisk